Home Gossamer Bio

Gossamer Bio

In operation
Post-IPO Round
Clinical-Stage Biopharmaceutical Company

Basic Information

Gossamer Bio is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutics in disease areas such as immunology, inflammation, and oncology. Its goal is to become an industry leader in these therapeutic fields and improve and extend the lives of patients suffering from such diseases.
Gossamer Bio, Inc.
SanDiego,California,United States of America
51~100 people
October 26, 2015
PR@GossamerBio.com